Activation of ATP-sensitive K+ channels: Mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside

European Journal of Pharmacology

Volumn 400, Issue 1, 2000, Pages 67-71

  Soares, Adriana C ^a   Leite, Rômulo ^a   Tatsuo, Maria A K F ^a   Duarte, Igor D G ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Antinociception; cGMP; K+ channel; Sodium nitroprusside

Indexed keywords

4 AMINOPYRIDINE; APAMIN; CESIUM; CHARYBDOTOXIN; CYCLIC GMP; GLIBENCLAMIDE; NITRIC OXIDE DONOR; POTASSIUM CHANNEL; POTASSIUM CHANNEL AFFECTING AGENT; TETRYLAMMONIUM; TOLBUTAMIDE;

ANALGESIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HINDLIMB; HYPERALGESIA; MALE; NONHUMAN; PAIN THRESHOLD; PAW EDEMA; POTASSIUM CURRENT; PRIORITY JOURNAL; RAT;

ADENOSINE TRIPHOSPHATE; ANALGESICS, NON-NARCOTIC; ANIMALS; APAMIN; CHARYBDOTOXIN; CYCLIC GMP; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; NITRIC OXIDE DONORS; NITROGLYCERIN; NITROPRUSSIDE; POTASSIUM CHANNELS; RATS; RATS, WISTAR; TOLBUTAMIDE;

EID: 0034648075     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00355-1     Document Type: Article

References (35)

1. Ahn D.K., Kim Y.S., Park J.S. Central NO is involved in the antinociceptive action of intracisternal antidepressants in freely moving rats. Neurosci. Lett. 243:1998;105-108.
2. Ali A., Bipozzi M.A., Burgos R.A., Carozzi R.G., Chierasco R.E., De Leon J.F., Gueglio R.J., Gutierrez G., Moisa C.F., Morales F., Moya R.A., Narancio A.E., Sergio R.F., Testa R.A. Transdermal nitroglycerin in the management of pain associated with primary dysmenorrhoea: a multinational pilot study. J. Intern. Med. Res. 25:1997;41-44.
3. + channels. Science. 247:1990;852-854.
4. + channels in cGMP-mediated pial artery vasodilatation. Am. J. Physiol. 270:1996;H423-H426.
5. Brodie M.S., Proudfit H.K. Hypoalgesia induced by local injection of carbachol into nucleus raphe magnum. Brain Res. 291:1984;337-342.
6. + channels. Am. J. Physiol. 273:1997;H76-H83.
7. Christensen M.H., Schulze S., Rosenberg J. Effect of sublingual nitroglycerin on pain following ERCP. Ugeskr. Laeg. 159:1997;1954-1959.
8. + channels of muscle cells - their properties, regulation, and functions. J. Bioenerg. Biomembr. 23:1991;509-535.
9. Dayton H.E., Garrett R. Production of analgesia by cholinergic drugs. Proc. Soc. Exp. Biol. Med. 142:1973;1011-1013.
10. Duarte I.D.G., Ferreira S.H. The molecular mechanism of central analgesia induced by morphine or carbachol and the L-arginine-nitric oxide - cGMP pathway. Eur. J. Pharmacol. 221:1992;171-174.
11. Duarte, I.D.G., Lorenzetti, B.B., Ferreira, S.H., 1990a. Acetylcholine induces peripheral analgesia by the release of nitric oxide, in: Science Publishers (eds.) Nitric Oxide from L-Arginine: A Bioregulatory System (Elsevier, London) pp. 165-170.
12. Duarte I.D.G., Lorenzetti B.B., Ferreira S.H. Peripheral analgesia and activation of the nitric-cyclic GMP pathway. Eur. J. Pharmacol. 186:1990;289-293.
13. + channels. Annu. Rev. Pharmacol. Toxicol. 33:1993;597-637.
14. Ferreira S.H., Nakamura M. Prostaglandin hyperalgesia, the peripheral analgesic activity of morphine, enkephalin and opioid antagonists. Prostaglandin. 18:1979;191-200.
15. Germany A., González P., Contreras E. Possible role of nitric oxide in the antinociception action of intraventricular bradykinin in mice. Eur. J. Pharmacol. 310:1996;123-127.
16. Iwamoto E.T., Marion L. Characterization of the antinociceptive action produced by intrathecally administered muscarinic agonists in rat. J. Pharmacol. Exp. Ther. 266:1993;329-338.
17. Katayama Y., Watkins L.R., Becker D.P., Hayes R.L. Non-opiate analgesia induced by carbachol microinjection into the pontine parabrachial region of the cat. Brain Res. 296:1984;263-283.
18. + channel in cultured vascular smooth muscle cells. Circ. Res. 74:1994;470-476.
19. Metys J., Wagner N., Metysoda J., Herz A. Studies on the central antinociceptive actions of cholinomimetics agents. Int. J. Neuropharmacol. 8:1969;413-425.
20. + channels. J. Physiol. 486:1995;47-58.
21. + channels in the cardiovascular system. Am. J. Physiol. 261:1991;H1675-H690.
22. 2-adrenoceptor, GABAB and κ-opioid receptor agonists. Br. J. Pharmacol. 110:1993;1049-1054.
23. 1 receptor agonist. Naunyn-Schmiedeberg's Arch. Pharmacol. 350:1994;57-62.
24. + channel blocker antagonizes morphine analgesia. Eur. J. Pharmacol. 186:1990;377-378.
25. + channel-acting drugs. Br. J. Pharmacol. 114:1995;1296-1302.
26. Pedigo N.W., Dewey W.L., Harris L.S. Determination and characterization of the antinociceptive activity of intraventricular administered acetylcholine in mice. J. Pharmacol. Exp. Ther. 193:1975;845-852.
27. Randall L.D., Selitto J.J. A method for measurement of analgesic activity on inflamed tissues. Arch. Int. Pharmacol. 113:1957;233-249.
28. 1A receptors. Eur. J. Pharmacol. 295:1996;181-188.
29. + channels. Br. J. Pharmacol. 129:2000;110-114.
30. + channels. Clin. Exp. Pharmacol. Physiol. 22:1995;635-636.
31. Thornbury K.D., Ward S.M., Dalziel H.H., Carl A., Westfall D.P., Sanders K.M. Nitric oxide and nitrocysteine mimic nonadrenergic, noncholinergic hyperpolarization in canine proximal colon. Am. J. Physiol. 26:1991;G553-G557.
32. + channels. Eur. J. Pharmacol. 193:1991;135-136.
33. Yaksh T.L., Dirksen R., Harty G.L. Antinociceptive effects of intrathecally injected cholinomimetic drugs in the rat and cat. Eur. J. Pharmacol. 117:1985;81-88.
34. Yonehara N., Takiuchi S. Involvement of calcium-activated potassium channels in the inhibitory prejunctional effect of morphine on peripheral sensory nerves. Regul. Pept. 68:1997;147-153.
35. +-channels. Invest. Ophthalmol. Visual Sci. 38:1997;1761-1767.